PARP Inhibitor–Based Combinations to Improve Patient Outcomes in Prostate Cancer: An Evidence-Based Global Perspective

Learn about PARP inhibitor–based combination therapy in prostate cancer in this expert-authored online activity with downloadable slides, podcasts and a ClinicalThought.
Johann Sebastian de Bono, MB, ChB, FRCP, MSc, PhD

ClinicalThought

Here are my thoughts on some of the ongoing clinical trials of combination therapy approaches using PARP inhibitors in advanced prostate cancer.

Johann Sebastian de Bono, MB, ChB, FRCP, MSc, PhD Released: January 25, 2021

Voici mes réflexions sur certains des essais cliniques en cours portant sur des associations thérapeutiques utilisant des inhibiteurs de la PARP dans le traitement du cancer avancé de la prostate.

Johann Sebastian de Bono, MB, ChB, FRCP, MSc, PhD Released: February 25, 2021

Estas son mis consideraciones sobre algunos de los ensayos clínicos en curso de enfoques de terapia combinada que utilizan inhibidores de PARP en el cáncer de próstata avanzado.

Johann Sebastian de Bono, MB, ChB, FRCP, MSc, PhD Released: February 25, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue